We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Inspections Becoming Heavy Issue for Generic User Fees Talks
Inspections Becoming Heavy Issue for Generic User Fees Talks
April 22, 2011
In the latest of a series of meetings with industries to establish generic user fees, the FDA provided additional perspective for generic-drug makers on the scope, number and type of domestic and foreign inspections to be funded by those fees.